Showing results (2111-2120 of 2,258) with videos related to

Sort By:
Pageof 226
Pacing and Clinical Electrophysiology : PACE|February 16, 2021
Sinus rhythm heart rate increase after atrial fibrillation ablation is associated with lower risk of arrhythmia recurrenceAmmar M Killu, Chance M Witt, Alan M Sugrue, et al.
Nature Immunology|August 9, 2011
The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammationKatarzyna Bulek, Caini Liu, Shadi Swaidani, et al.
Diabetes|February 1, 1996
Report of the American Diabetes Association's Task Force on standardization of the insulin assayD C Robbins, L Andersen, R Bowsher, et al.
Pharmacology Research & Perspectives|February 9, 2018
Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjectsJan Hillson, Tim Mant, Molly Rosano, et al.
Molecular Imaging|August 19, 2008
Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agentsJerry D Glickson, Sissel Lund-Katz, Rong Zhou, et al.
Future Oncology (London, England)|May 28, 2025
Impact of comorbidity on immune-related adverse events and survival in older cancer patients treated with immunotherapyAlyssa A Guo, Mary-Peyton Knapp, Joni K Evans, et al.
Advances in Experimental Medicine and Biology|February 21, 2009
Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agentsJerry D Glickson, Sissel Lund-Katz, Rong Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2020
Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysinGulbag Kahlon, Rogelio Lira, Nikolay Masvlov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2022
Innate and Adaptive Immunity to Transfused Allogeneic RBCs in Mice Requires MyD88Arielle Soldatenko, Laura R Hoyt, Lan Xu, et al.
Therapeutic Advances in Medical Oncology|October 31, 2022
Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literatureLara M Khoury, Kimberly M Burcher, Ronald T Ng, et al.
Pageof 226